Hudson Bay Capital Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Hold |
428,317
| – | – | ﹤0.01% | 658 |
|
|
2025
Q1 | $947K | Buy |
428,317
+213,074
| +99% | +$471K | ﹤0.01% | 601 |
|
|
2024
Q4 | $1.17M | Buy |
215,243
+87,846
| +69% | +$479K | ﹤0.01% | 545 |
|
|
2024
Q3 | $1.06M | Sell |
127,397
-345,396
| -73% | -$2.87M | ﹤0.01% | 485 |
|
|
2024
Q2 | $3.39M | Sell |
472,793
-63
| -0% | -$451 | 0.02% | 364 |
|
|
2024
Q1 | $4.1M | Sell |
472,856
-1,197,085
| -72% | -$10.4M | 0.02% | 289 |
|
|
2023
Q4 | $10.9M | Buy |
1,669,941
+1,010,544
| +153% | +$6.62M | 0.07% | 139 |
|
|
2023
Q3 | $6.59M | Buy |
659,397
+416,876
| +172% | +$4.17M | 0.05% | 197 |
|
|
2023
Q2 | $3.01M | Buy |
+242,521
| New | +$3.01M | 0.02% | 372 |
|
|
2021
Q4 | – | Sell |
-90,000
| Closed | -$4.42M | – | 1133 |
|
|
2021
Q3 | $4.42M | Buy |
+90,000
| New | +$4.42M | 0.06% | 380 |
|